COOPER COMPANIES, INC. News

company, COO

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

see more

COOPER COMPANIES, INC. Market News

9d

Cooper Companies Reports Significant Revenue Growth in Q2 2026 Amid Strategic Acquisitions

  • San Ramon, CA — August 13, 2026 — The Cooper Companies, Inc. (NYSE: COO), a global leader in medical devices, reported robust financial results for the second quarter of fiscal year 2026, alongside strategic initiatives that have influenced its stock performance.
CTA-image

1w 1m 6m 1Y Max